Aytu Biopharma, Inc. (AYTU)
2.56
-0.01
(-0.39%)
USD |
NASDAQ |
May 06, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Aytu Biopharma Total Liabilities (Quarterly) : 107.80M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Illumina, Inc. | 3.883B |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Agenus, Inc. | 504.66M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Savara, Inc. | 50.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Shareholders Equity (Quarterly) | 14.20M |
| Debt to Equity Ratio | 1.556 |
| Current Ratio | 1.163 |
| Net Debt Paydown Yield | -2.81% |